Antinobac

Actinobac Biomed is developing therapeutics for multiple indications including blood cancers, autoimmune, inflammatory diseases and HIV.

Business Model:

Revenue: $5M

Employees: 201-500

Rankings

Detailed Antinobac Information

Geographic Data

Antinobac headquarters map

Address: 15 Pelham Rd

City: Kendall Park

State: NJ

Zip: 08824

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$1M

Raised Total:

$3M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Actinobac Biomed is developing therapeutics for multiple indications including blood cancers, autoimmune, inflammatory diseases and HIV.

Contact Phone:
+17323712694

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
10/2014 Grant $905k National Institutes of Health
National Cancer Institute
6/2018 Venture Round $1M
7/2017 Equity $2.4M Kairos Ventures
2/2013 Seed Round 1 $100k Foundation Venture Capital Group
Foundation Venture Capital Group
7/2017 Venture Round 1 $4.4M Kairos Ventures
Kairos Ventures
3/2009 Seed Round 1 $500k Foundation Venture Capital Group
Foundation Venture Capital Group
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research